The 20th edition of BioAsia – The Marquee Healthcare and Life Sciences event, organized by the Government of Telangana, has announced that the coveted Genome Valley Excellence Award for the year 2023 will be conferred upon Prof. Robert S. Langer, in light of his pioneering research that has led to the development of the first commercial mRNA vaccines used for a variety of infectious diseases. Langer is currently the David H. Koch Institute Professor at Massachusetts Institute of Technology (MIT), USA. He is also being acknowledged for his exemplary research in human health, including the detection, monitoring, and treatment of cancer. A veteran in his field, his remarkable contributions to biomedical and therapeutic research include developing long-term and controlled-release drug delivery systems used for a variety of applications including cancer therapy, insulin, and vaccines.
Related Posts
Loylty Rewardz Achieves Prestigious PCI DSS v4.0.1 Certification, Setting a New Security Benchmark for India’s Loyalty Industry
Business Wire India Loylty Rewardz, a leading provider of customer engagement and loyalty solutions, today announced it has successfully achieved…
Sterlite Power commissions its sixth power transmission project in Brazil
Mumbai, 21st July 2023 – Sterlite Power, a leading power transmission developer and solutions provider, has achieved a significant milestone…
MSME Minister Shri Narayan Rane launches IndiaXports 2.0 to facilitate 200K first-time exporters through e-commerce
New Delhi, 25th November 2023: India SME Forum (ISF), India’s largest non-governmental, not-for-profit organization for small and medium businesses, hosted…